Engineering for Precision Therapeutics
At the forefront of what we are doing are our antibody engineering capabilities to design novel molecules that address inflammation and cancer.
OncoOne's Antibody Technology
The pioneers for oxMIF and wizards of antibody engineering are advancing precision medicine with cutting edge technologies. Monoclonal antibodies have revolutionized immunotherapy and are the preferred modalities to target cytokines and tumor antigens. Antibody engineering competencies are critical to optimize their therapeutic potential. At OncoOne, our world-class team of antibody engineers develop and optimize unique, tailored antibodies (mAbs) with precisely defined functionalities, specifically engineered for individual therapeutic indications.
OncoOne is pioneering two cutting-edge technology platforms that are unlocking a new era of therapeutic breakthroughs.
These transformative platforms, driven by antibody engineering, are poised to revolutionize the treatment of major chronic inflammatory and oncological diseases.
